» Articles » PMID: 29114141

Effect of Phenyl Vinyl Sulphone Cysteine Protease Inhibitor on : in Vitro and in Vivo Experimental Studies

Overview
Journal J Parasit Dis
Specialty Parasitology
Date 2017 Nov 9
PMID 29114141
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The present work aimed to study the effect of phenyl vinyl sulphone (PVS), a CPI, on different stages of Schistosoma (S.) mansoni in an in vitro culture study and in experimentally infected mice, compared to PZQ. As regards the in vitro study, different concentrations of PVS (1, 2, 4, 6, 8 and 10 µg/ml) and PZQ (1 µg/ml) were assessed by % worm mortality for schistosomula and adults, and hemoglobin degradation by schistosomula. In vivo study included 8 groups of mice. Intraperitoneal PVS, subgroup (a), and oral PZQ, subgroup (b), were assessed at different durations post infection (pi); at 1, 3, 5 and 7 weeks pi (groups I, II, III and IV, respectively). Infection, PVS, PZQ, and normal control groups (groups V-VIII) were included. The anti-schistosomal effects of PVS were assessed by parasitological, histopathological and haematological parameters. In in vitro study, PVS had a schistosomicidal effect in a concentration and time dependent manner, PVS showed 100% schistosomula mortality at day 2 and 92% adult worm mortality at day 5. Furthermore, PVS decreased hemoglobin degradation by schistosomula. In in vivo study, PVS showed a decrease in total worm burden and tissue egg load in intestine and liver with an increase in number of dead ova in intestine of mice. Furthermore, PVS resulted in a decrease in number, size and cellularity of hepatic granulomas and an increase in hemoglobin concentration.PVS was better than PZQ in reducing each of tissue egg count in intestine at 5 and 7 weeks pi, and hepatic granuloma size at 3, 5 and 7 weeks pi. These results suggest that PVS can be a promising chemotherapeutic agent in infection.

Citing Articles

Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni.

Mohammad O, Hussein H, Abdel-Sayed S, Mohamed G, Shehata M Parasitol Res. 2024; 123(5):215.

PMID: 38771511 DOI: 10.1007/s00436-024-08236-8.

References
1.
El-Beshbishi S, Taman A, El-Malky M, Azab M, El-Hawary A, El-Tantawy D . First insight into the effect of single oral dose therapy with artemisinin-naphthoquine phosphate combination in a mouse model of Schistosoma mansoni infection. Int J Parasitol. 2013; 43(7):521-30. DOI: 10.1016/j.ijpara.2013.01.007. View

2.
Helmy M, Fahmy Z, Sabry H . Fasciola gigantica: evaluation of the effect of phenyl vinyl sulfone in vitro. Exp Parasitol. 2008; 119(1):125-34. DOI: 10.1016/j.exppara.2008.01.002. View

3.
Abdulla M, Lim K, Sajid M, McKerrow J, Caffrey C . Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Med. 2007; 4(1):e14. PMC: 1764436. DOI: 10.1371/journal.pmed.0040014. View

4.
CHEEVER A . Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bull World Health Organ. 1968; 39(2):328-31. PMC: 2554554. View

5.
Smithers S, Terry R . The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology. 1965; 55(4):695-700. DOI: 10.1017/s0031182000086248. View